Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress

Go back to Fate Therapeutics Reports Second Quarter 2021 Financial Results and Highlights Operational Progress
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.08 -0.09 (4.15%)
Previous Close $2.17    52 Week High $4.76 
Open $2.13    52 Week Low $1.46 
Day High $2.17    P/E N/A 
Day Low $2.01    EPS $-1.91 
Volume 1,064,419       

(NASDAQ: LEGN) Delayed: 21.63 -0.67 (3%)
Previous Close $22.30    52 Week High $ 
Open $22.12    52 Week Low $ 
Day High $22.42    P/E N/A 
Day Low $21.34    EPS $ 
Volume 2,189,663